AA
NUVL

AlphaCentric Advisors’s Nuvalent NUVL Stock Holding History

AlphaCentric Advisors’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$686K Buy
5,558
+901
+19% +$96.9K 0.58% 53
2026
Q1 		$477K Buy
4,657
+253
+6% +$25.8K 0.48% 66
2025
Q4 		$443K Buy
+4,404
New +$434K 0.44% 69
2024
Q4 		– Sell
-7,000
Closed -$716K – 264
2024
Q3 		$716K Buy
+7,000
New +$581K 0.53% 58
2023
Q2 		– Sell
-17,897
Closed -$467K – 262
2023
Q1 		$467K Buy
17,897
+2,397
+15% +$70.9K 0.32% 87
2022
Q4 		$462K Buy
+15,500
New +$432K 0.46% 74

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

AlphaCentric Advisors's NUVL Position: Q2 2026 in Review

AlphaCentric Advisors increased its Nuvalent (NUVL) stake by 19% in Q2 2026, buying an estimated $96.9K and bringing the position to 5,558 shares worth $686K. The position accounts for 0.58% of the portfolio, ranked #53.

AlphaCentric Advisors first reported a position in NUVL in Q4 2022 and has held it in 6 quarters since. The position peaked at $716K in Q3 2024. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • AlphaCentric Advisors held 5,558 shares of Nuvalent worth $686K as of Q2 2026.
  • AlphaCentric Advisors bought 901 Nuvalent shares in Q2 2026, an estimated $96.9K.
  • Nuvalent made up 0.58% of AlphaCentric Advisors's portfolio in Q2 2026, its #53 holding.
  • AlphaCentric Advisors first reported a position in Nuvalent in Q4 2022 and has held it in 6 quarters since.
  • AlphaCentric Advisors's Nuvalent position peaked at $716K in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.